Orthofix releases study on additional therapy for lumbar spinal fusion procedures

Spinal Tech

Spine and orthopedic products company Orthofix released new data on pulsed electromagnetic field stimulation, an additional therapy to lumbar spinal fusion procedures for patients at risk for pseudarthrosis.

The study investigated patients using Orthofix's SpinalStim bone growth therapy device experienced less pain as well as increased function and quality of life, according to a Dec. 21 news release from Orthofix. 

Conducted at 10 centers in the U.S., the study included a total of 142 patients with one or more risk factors for pseudarthrosis. The patients used SpinalStim for six months after the procedure and over 82 percent experienced a successful fusion. 

The study was published in the International Journal of Spine Surgery, the release said. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers